Trabeculectomy with Healaflow versus Trabeculectomy for the Treatment of Glaucoma: A Case-Control StudyReportar como inadecuado

Trabeculectomy with Healaflow versus Trabeculectomy for the Treatment of Glaucoma: A Case-Control Study - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

Journal of Ophthalmology - Volume 2015 2015, Article ID 836269, 7 pages -

Clinical StudyDepartment of Ophthalmology, “G. Gennimatas” Hospital, University of Athens, Mesogeion Avenue, 11527 Athens, Greece

Received 19 February 2015; Revised 3 May 2015; Accepted 25 May 2015

Academic Editor: Enrique Mencía-Gutiérrez

Copyright © 2015 Dimitris Papaconstantinou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Purpose. To compare the outcomes of trabeculectomy with and without Healaflow Anteis S.A, Geneva, Switzerland, a high molecular weight viscoelastic gel, in patients requiring glaucoma surgery. Methods. This was a retrospective, comparative, interventional case-control study. Forty patients formed two matched study groups and were analyzed trabeculectomy alone control versus trabeculectomy with Healaflow study. Results. The postoperative levels of mean IOP were statistically significantly lower than preoperatively in both groups, for all time intervals. There was no statistical difference, at the end of the follow-up period, between the two groups in the mean values of the IOP 14.9 ± 3.2 mmHg for the study group versus 14.8 ± 3.3 mmHg for the control group. The number of antiglaucoma drugs used in the study group was reduced from a preoperative mean of 3.4 ± 0.75 to a 6-month postoperative mean of 0.6 ± 0.8 and in the control group from 3.6 ± 0.59 to 0.55 ± 0.9 . Conclusions. Although trabeculectomy with Healaflow appears to be a safe procedure, we failed to identify any significant advantages in the use of Healaflow when compared with trabeculectomy alone, at the end of the 6-month follow-up period.

Autor: Dimitris Papaconstantinou, Andreas Diagourtas, Petros Petrou, Alexandros Rouvas, Athanasios Vergados, Chryssanthi Koutsandrea



Documentos relacionados